Xenon CEO reports Form 4P transaction
Xenon Pharmaceuticals said President & CEO Mortimer Ianp filed Form 4P covering 30,000 shares at $37.38, or $1,121,400.
Xenon Pharmaceuticals said President & CEO Mortimer Ianp filed Form 4P covering 30,000 shares at $37.38, or $1,121,400.